Introduction
The Advisory Committee on Immunization Practices (ACIP) at the US Centers for Disease Control and Prevention (CDC) 1 now recommends annual influenza vaccination for all people aged 6 months and older unless contraindicated. The ACIP is the only entity in the US federal government that formulates recommendations on the use of vaccines by the US civilian population based on careful review of the scientific evidence.
2 Through endorsements by medical professional societies and public health authorities, ACIP recommendations influence the nature of public health communication about vaccination and the vaccine-related practices of healthcare provides. The new ACIP recommendations of near universal annual influenza vaccination were also publicized in the news media and on the Internet, using some of the same communication tools that had been deployed for informing the public during the 2009 influenza A ⁄ H1N1 pandemic (see, e.g., Flu.gov, Accessed 9 August 2011). 3 Prior to the 2010-2011 vaccination season, annual vaccination for influenza was based on a complex array of personal characteristics such as age, occupation, living arrangements, and existing health conditions that put individuals at elevated risk of transmitting and contracting influenza or suffering serious complications from a potential influenza infection. 4 Pieced together, the risk-based recommendations covered roughly 80% of the total US population.
By extending recommendations to all healthy adults aged 18-49 years, the ACIP influenza vaccination recommendations became near universal. While the merits of a near universal influenza vaccination recommendation have long been debated, the recent pandemic brought home the fact that novel strains of influenza can cause severe illness in otherwise healthy, ''low-risk'' people. Moreover, vaccinating healthy people also helps to protect their close contacts who may be highly vulnerable to influenza and its complications.
The new universal recommendation will also simplify administrative procedures for influenza vaccination according to ACIP guidelines by eliminating the step of verifying patients' recommendation status before discussing vaccination with patients in clinical practice. For example, previous research indicates that only one half of physician practices were able to generate lists of patients with chronic illnesses at high risk for complications of influenza. These practices, in turn, were significantly more likely to use patient reminders for influenza vaccination. 5 While the universal vaccination recommendation simplifies administrative procedures, it does not eliminate the need to identify subgroups with low vaccination rates, who are unaware of being recommended for annual influenza vaccination and to target information about the benefits of vaccination to these patient groups. To date, there is no evidence regarding whether the US public is aware of the new universal recommendation. Based on the experience of last year's pandemic, we suspect that healthy young adults remain relatively unaware of being newly recommended for annual influenza vaccination. During the pandemic, only one-third of US adults who were recommended for either or both seasonal or H1N1 influenza vaccination were aware of it, highlighting gaps in public awareness about the risks and benefits of influenza vaccination. 6 To test this hypothesis, we analyzed recently collected nationally representative data on perceived recommendation status for influenza vaccination among US adults and estimated its association with socio-demographic characteristics and coverage by ACIP's previous, less comprehensive influenza vaccination recommendations for the 2009-2010 pandemic vaccination season. Comparing the perceived recommendation status of newly and previously recommended persons, thereby, allows us to assess whether the new universal recommendations have already resulted in levels of awareness among newly recommended adults that are comparable with those among persons who have already been recommended for influenza vaccination during past vaccination seasons.
Methods
We employed survey data from two waves (9 and 12) of a twelve-wave longitudinal survey effort to monitor US . Data on our outcome of interest -adults' knowledge of their own influenza vaccination recommendation status -were collected in wave 12 of the survey, which was completed by 2628 ALP members (completion rate: 80AE8 percent). 80AE7 percent of wave 12 respondents had previously completed wave 9 of the survey, which gathered comprehensive information about respondents' influenza risk characteristics corresponding to the criteria used by ACIP to define its seasonal and H1N1 vaccination recommendations during the 2009-2010 pandemic. 4, 7 Our final analytical sample consisted of n = 2122 respondents who responded to both survey waves (waves 9 and 12). Combining the two survey waves did not only allow us to measure adults' awareness of being currently covered by an influenza vaccination recommendation, but also permitted us to study the relationship between their current awareness of their recommendation status for influenza vaccination relative to their recommendation status during the 2009 influenza A ⁄ H1N1 pandemic.
Awareness of being recommended for influenza during the 2010-2011 vaccination season was measured by asking: ''Each year, the federal government recommends which members of the general population should get a flu vaccine. According to government recommendations, are you recommended to get the flu vaccine this flu season (August 2010 to May 2011)? '' Permissible answers were ''Yes,'' ''No,'' and ''Don't know'' and we combined the categories ''No,'' and ''Don't know,'' indicating lack of knowledge about being covered by a government vaccination recommendation for influenza.
We determined whether the respondents were recommended for seasonal and ⁄ or H1N1 vaccination during the 2009-2010 pandemic based on the risk factors measured in November ⁄ December 2009 (wave 9), the midpoint of the pandemic. During this time, both seasonal and pandemic vaccinations were recommended for healthcare workers, pregnant women, adults aged 25-64 years with a high-risk health condition, such as asthma, heart disease or diabetes,
ª 2011 Blackwell Publishing Ltd and adults with regular contact with children age 6 months or younger. Seasonal vaccination was recommended for all adults aged 50 years and older as well as for the persons in regular contacts with adults aged 50 years and older or children age 5 or younger. H1N1 vaccination was recommended for all adults aged 18-24 years. Based on corresponding measures available in survey wave 9, we constructed detailed control variables for coverage by an influenza vaccination recommendation during the past pandemic season 2009-2010. Specifically, we constructed age controls interacted with indicator variables for the presence of a high-risk health condition as well as additional controls for regular contact with high-risk individuals, which mirrored the ACIP recommendation criteria for seasonal and pandemic vaccination of adults during the pandemic. In addition to detailed controls for adults' recommendation status for influenza vaccination during the 2009 influenza A ⁄ H1N1 pandemic, the model also included controls for respondents' sex, race, educational attainment, family income, and work status.
Statistical analyses were performed using STATA SE 10.1 software (StataCorp, College Station, TX, USA). Sample characteristics and unadjusted associations were computed using proportion estimation. Adjusted associations were computed using a probit model that incorporated all of the above controls simultaneously and were reported in terms of average partial effects, i.e., the average percentage point change in the probability of self-reported coverage by a government vaccination recommendation for influenza associated with a one-unit change in the value of a given variable of interest, controlling for other characteristics. All estimates were weighted to be nationally representative for the US adult population using probability weights that reflect the distribution of selected demographic characteristics of the US adult population as obtained from the US Current Population Survey (CPS). The RAND Corporation's Institutional Reviewed Board approved the study design and surveys.
Results
Overall, 46AE2 percent of US adults correctly reported to be covered by a government recommendation for influenza vaccination during the 2010-2011 vaccination season (Table 1) . Table 1 also reports unweighted sample sizes and weighted prevalence rates for all control variables along with their unadjusted associations with respondents' knowledge regarding their influenza vaccination recommendation status. Knowledge of influenza vaccination status varied significantly by race and ethnicity (P = 0AE026), with the highest level of knowledge among non-Hispanic whites (49AE1 percent). Likewise, knowledge was considerably higher among non-working than among working respondents (67AE3 percent versus 37AE8 percent, P < 0AE001) and among respondents who were recommended for seasonal vaccination (56AE4 percent) or for both H1N1 and seasonal vaccination (54AE8 percent) during the 2009-2010 pandemic (P < 0AE001). In addition, Table 1 shows considerable variation in self-reported coverage by a 2010-2011 government influenza vaccination recommendation across the different criteria of the targeted recommendations during the 2009-2010 pandemic. Adults aged 65 years and older with and without a high-risk health condition displayed the highest level of knowledge (88AE3 percent and 84AE4 percent), followed by adults aged 50-64 years with a high-risk health condition (73AE7 percent) and healthcare workers (67AE5 percent). Self-reported coverage by a government vaccination recommendation was substantially lower among all other groups, rarely exceeding 50 percent. Table 2 reports adjusted associations obtained from multivariable probit models that simultaneously control for socio-demographic characteristics and 2009-2010 recommendation status. The latter is measured using the more detailed set of controls for membership in a specific recommendation group to capture the large, age-related variation in self-reported coverage by a 2010-2011 government influenza vaccination recommendation within the different 2009-2010 recommendations groups document in Table 1 . Accounting for 2009-2010 recommendation status, we found no statistically significant associations between knowledge of adults' current recommendation status and their socio-demographic characteristics with the exception of work status. Everything else equal, working adults were 9AE6 percentage points less likely to know about being recommended for influenza vaccination than their nonworking counterparts.
In addition, the probit model showed that self-reported coverage by a government vaccination recommendation for the 2010-2011 vaccination season is closely related to age and health status that defined previous recommendations during the 2009-2010 pandemic and before. Persons aged 18-49 years with a high-risk health condition were 12AE9 percentage points more likely to know about being recommended for influenza vaccination than adults who were not recommended for influenza vaccination in the past (omitted category). Persons age 50-64 without and with a high-risk health condition were 21 and 36AE7 percentage points more likely to know about their current recommendation status than newly recommended persons who were not by an age-or health-related government influenza vaccination recommendation in the past. Corresponding average partial effects for persons age 65 and older without and with a high-risk health condition were 43AE4 and 47AE8 percentage points, respectively. Controlling for other factors, young healthy adults aged 18-24 years, who were only recommended for H1N1 vaccination during the 2009-2010 vaccination season, displayed a 4AE3 percentage point lower levels of knowledge about being recommended for influenza vaccination during the 2010-2011 influenza season than healthy adults aged 25-49 years. Healthcare workers were 23AE5 percentage points more likely to know about being recommended for influenza vaccination than newly recommended persons, but the corresponding association was considerably smaller and statistically insignificant for household contacts of high-risk individuals. Moreover, pregnant women or persons with regular contact with infants aged 6 months or less showed no increased knowledge about being recommended for influenza vaccination compared with newly recommended healthy adults aged 25-49 years.
Discussion
Our study showed that at the start of the 2010-2011 influenza vaccination season, less than half of US adults knew that they were recommended for influenza vaccination by the US government. This finding highlights the magnitude of outreach required of public health officials and healthcare providers to increase adults' awareness of their 7, 8 The relatively low levels of awareness among newly recommended adults compared to adults who have already been recommended for seasonal influenza vaccination in the past also reveal limited awareness of last year's changes in ACIP's influenza vaccination recommendations and highlight the need for additional communication efforts highlighting the universal nature of the new vaccination recommendations for influenza. Particularly, as awareness seems especially low among working adults, employer-based outreach programs such as employer-based reminder systems and company flu shot clinics may be a promising tool for increasing awareness and cost-effective vaccine use among newly targeted young, healthy adults. 9 Similarly, the comparatively low rates of awareness among certain traditional recommendation groups such as pregnant women and household contacts of infants call for increased efforts to highlight the importance of influenza vaccination for pregnant women and caregivers of young children during routine care visits to obstetricians or pediatricians.
Our study has several limitations. First, despite adopting a probability-based sample design that covers both online and offline households, the decision to participate in the ALP could be associated with awareness of one's recommendation status in a way that compromises the external validity of our findings. Likewise, as many ALP members participated in several influenza vaccination surveys during the pandemic, ''learning effects'' or panel conditioning may have affected our results. Particularly, our estimates of knowledge of adults' recommendation status are somewhat larger compared with previous estimates of adults' awareness of their influenza vaccination recommendation status during the pandemic 6 . This difference may reflect genuine increases in the awareness of adults with regard to government influenza vaccination recommendations or confusion during the pandemic with regard to the distinct recommendations for seasonal and pandemic vaccination, respectively, but may also reflect differences in sample source, survey methodology, or potential learning effects. In general, our estimates appear conservative, as both potential biases mentioned earlier suggest that adults' awareness of their government recommendation status for influenza vaccination is, if anything, estimated too high.
The new universal vaccination recommendation for influenza should facilitate the streamlining of public health communication and the initiation of counseling by healthcare providers about the benefits of annual influenza vaccination. This is because compliance with official recommendations no longer requires time-consuming administrative procedures aimed at identifying subgroups of recommended patients based on their age, health, or contact with high-risk individuals, many of which are not routinely documented in medical record and other administrative data. In this way, messaging can more efficiently address the attitudinal and access barriers to vaccination irrespective of demographic and clinical characteristics. Eliminating the administrative complexity associated with targeting recommended subgroups based on demographic and clinical characteristics should facilitate the implementation of evidence-based, but underused strategies for communicating the benefits of vaccination, including oneon-one counseling by healthcare providers during office visits, the use of phone, email, or postcard patient reminders of physicians and employers or the increased use of social media. [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] However, the universal vaccination recommendations will only be successful if they reach both patients and physicians and lead to changing vaccination practices. It has never been easier.
